Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. HONA

Go back to Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis
(NASDAQ: MDCX) Delayed: 0.17 --0 (-0%)
Previous Close $0.17    52 Week High $ 
Open $0.16    52 Week Low $ 
Day High $0.18    P/E N/A 
Day Low $0.16    EPS $ 
Volume 15,867,024       

(NASDAQ: MDCX) Delayed: 0.17 --0 (-0%)
Previous Close $0.17    52 Week High $ 
Open $0.16    52 Week Low $ 
Day High $0.18    P/E N/A 
Day Low $0.16    EPS $ 
Volume 15,867,024